A number of data points this week – including our own Impact 50 list – point to continued LP enthusiasm for private markets impact.
The appetite for Eurazeo's debut transition strategy shows the power of impact to driver allocations, says co-CEO Christophe Bavière.
Strathclyde Pension Fund has allocated £15m to Temporis Capital's impact strategy, a regulatory filing shows.
Forbion, a life sciences venture capital firm, has held a first close on €75m for Forbion BioEconomy Fund I, which is targeting €150m.
The latest investments bring the total amount raised to £210m.
Obligo said that it has already deployed capital from the fund into six investments with 'several more in the pipeline'.
Spanish GP Creas reached a first close after a €20m commitment from the European Investment Fund.
Eurazeo's first transition fund overcame LP hesitation to close oversubscribed at €663m, with another €43m in co-investments.
The firm, which is backed by a group of oil and gas majors, will market its second early-stage fund as it also establishes a growth equity strategy.
Inverness Graham is looking to invest in the agtech transition, energy transition, industrial transition and built world transition.